Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
British Journal of Pharmacology|March 1, 1983
Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptorsJ C Doxey, A G Roach, C F Smith
European Journal of Pharmacology|March 24, 1992
Comparison of the effects of efaroxan and glibenclamide on plasma glucose and insulin levels in ratsT L Berridge, J C Doxey, A G Roach
The Journal of Clinical Endocrinology and Metabolism|November 1, 1988
Alpha 2-adrenoceptor blockade does not enhance glucose-induced insulin release in normal subjects or patients with noninsulin-dependent diabetesC G Ostenson, J Pigon, J C Doxey, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1983
Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptorsA G Roach, J C Doxey, D A Strachan, et al.
The American Journal of Physiology|September 1, 1989
Alpha-adrenoceptors and insulin release from pancreatic islets of normal and diabetic ratsC G Ostenson, A G Cattaneo, J C Doxey, et al.
British Journal of Pharmacology|September 1, 1983
Evidence for pharmacological similarity between alpha 2-adrenoceptors in the vas deferens and central nervous system of the ratJ C Doxey, B Gadie, A C Lane, et al.
British Journal of Pharmacology|November 1, 1984
Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systemsJ C Doxey, A G Roach, D A Strachan, et al.
Journal of Pharmacological Methods|September 1, 1987
The use of ex vivo platelet aggregation to confirm the in vivo alpha 2-adrenoreceptor antagonist effect of idazoxan in manN C Muir, J C Doxey, M E Havler, et al.
European Journal of Pharmacology|October 23, 1990
Selective alpha 2-adrenoceptor blockade does not enhance glucose-evoked insulin releaseG W John, J C Doxey, D S Walter, et al.
European Journal of Pharmacology|March 24, 1992
Selectivity profile of the alpha 2-adrenoceptor antagonist efaroxan in relation to plasma glucose and insulin levels in the ratT L Berridge, J C Doxey, A G Roach, et al.
Pageof 3